Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses.
Most antiviral treatment options target the invading pathogen and unavoidably encounter loss of efficacy as the pathogen mutates to overcome replication restrictions. A good strategy for circumventing drug resistance, or for pathogens without treatment options, is to target host cell proteins that a...
Main Authors: | Marta J Gonzalez-Hernandez, Anupama Pal, Kofi E Gyan, Marie-Eve Charbonneau, Hollis D Showalter, Nicholas J Donato, Mary O'Riordan, Christiane E Wobus |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3983190?pdf=render |
Similar Items
-
Small molecule deubiquitinase inhibitors promote macrophage anti-infective capacity.
by: Marie-Eve Charbonneau, et al.
Published: (2014-01-01) -
Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response.
by: Jeffrey W Perry, et al.
Published: (2012-01-01) -
Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
by: Seonghyeon Moon, et al.
Published: (2021-06-01) -
The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway.
by: Lele Zhang, et al.
Published: (2018-11-01) -
Deubiquitinases in Neurodegeneration
by: Abudu I. Bello, et al.
Published: (2022-02-01)